Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications

Acta Ophthalmologica Scandinavica
Per FlesnerHenrik Lund-Andersen

Abstract

This study presents an evaluation of cataract surgery on diabetic patients. One experienced surgeon carried out phaco emulsification on all subjects and the same surface-coated one-piece PMMA-lens-type was implanted. The lens fluorescence and the blood-aqueous barrier (BAB) were then evaluated as experimental preoperative risk indicators. During follow-up, 10 out of 39 diabetic patients progressed unilaterally in diabetic retinopathy or developed macular oedema, a significant relative risk. Neither lens fluorescence, BAB, HbA1c, level of retinopathy, type/duration of diabetes, diabetes treatment or antihypertensive treatment differed significantly between the group of patients with postoperative progression of retinopathy/macular oedema and those without. Results indicated NIDDM (non-insulin-dependent diabetes mellitus/type 2 diabetes) patients might have increased risk of a postoperative macular oedema. When diabetic retinopathy (DR) is not in a proliferative phase it should not be regarded as a contraindication to modern cataract surgery. Neither lens fluorescence nor BAB is valuable as a risk indicator for postoperative progression of DR.

References

Apr 1, 1992·The British Journal of Ophthalmology·A PollackM Oliver
Jan 1, 1992·The British Journal of Ophthalmology·J M SparrowH A Neil
Sep 1, 1991·The British Journal of Ophthalmology·A PollackM Oliver
Oct 1, 1990·Documenta Ophthalmologica. Advances in Ophthalmology·H J Van den BromL J Blanksma
Jan 1, 1989·Documenta Ophthalmologica. Advances in Ophthalmology·J P BootJ A Oosterhuis
Jan 1, 1989·Archives of Ophthalmology·M LarsenH Lund-Andersen
Mar 1, 1988·Experimental Eye Research·M OimomiM Yamamoto
Apr 1, 1995·Diabetes Research and Clinical Practice·M SensiD Andreani
Mar 15, 1994·American Journal of Ophthalmology·H SchatzR N Johnson
Jun 15, 1994·American Journal of Ophthalmology·A P MoriartyM Bulsara
Apr 1, 1996·The British Journal of Ophthalmology·J van BestR Schalnus
Jan 1, 1996·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·S RotersM Diestelhorst
Sep 1, 1996·The British Journal of Ophthalmology·M HenricssonL Janzon
Dec 1, 1996·Diabetologia·P Koefoed TheilH Lund-Andersen
Jan 1, 1996·Eye·R J AntcliffD W Flanagan
Jun 22, 1999·Journal of Cataract and Refractive Surgery·S KatoT Oshika

❮ Previous
Next ❯

Citations

Sep 10, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Urban ErikssonAnna Wikberg Matsson
Mar 20, 2004·Journal of Cataract and Refractive Surgery·David HauserAyala Pollack
Dec 3, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ali SalehiZahra Naderi Beni
Dec 20, 2012·Wiener klinische Wochenschrift·Michael SturAndreas Wedrich
Sep 6, 2011·Journal of Cataract and Refractive Surgery·Christoffer OstriMorten La Cour
Jun 13, 2006·Journal of Cataract and Refractive Surgery·George K EscaravageCassandra M Janowski
Apr 8, 2016·Wiener klinische Wochenschrift·Stephan RaddaKatharina Krepler
Oct 18, 2014·Seminars in Ophthalmology·Nour Maya N HaddadPaolo S Silva
Jan 9, 2010·International Ophthalmology Clinics·Saadia Rashid, Lucy H Young
Jan 25, 2003·Current Opinion in Ophthalmology·Mark L Nelson, Adam Martidis
Sep 7, 2018·Expert Opinion on Pharmacotherapy·Valentina SaraoPaolo Lanzetta
Apr 14, 2019·Wiener klinische Wochenschrift·Stephan RaddaUNKNOWN die Netzhautkommission der Österreichischen Ophthalmologischen Gesellschaft

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.